Phase 2 Randomized Controlled Trial Using Biologics to Improve Multi OIT Outcomes

Conditions:   Hypersensitivity;   Food Allergy;   Hypersensitivity, Food;   Peanut Hypersensitivity;   Peanut Allergy Interventions:   Drug: Omalizumab;   Drug: Dupilumab Sponsor:   Stanford University Not yet recruiting (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2OGvycv